These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20844023)

  • 1. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.
    Eliopoulos N; Zhao J; Bouchentouf M; Forner K; Birman E; Yuan S; Boivin MN; Martineau D
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1288-98. PubMed ID: 20844023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cells protect against acute tubular injury via an endocrine effect.
    Bi B; Schmitt R; Israilova M; Nishio H; Cantley LG
    J Am Soc Nephrol; 2007 Sep; 18(9):2486-96. PubMed ID: 17656474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
    Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice.
    Eliopoulos N; Zhao J; Forner K; Birman E; Young YK; Bouchentouf M
    Mol Ther; 2011 Nov; 19(11):2072-83. PubMed ID: 21847101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
    Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
    Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.
    Yuan L; Wu MJ; Sun HY; Xiong J; Zhang Y; Liu CY; Fu LL; Liu DM; Liu HQ; Mei CL
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F207-18. PubMed ID: 20943766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential.
    di Bonzo LV; Ferrero I; Cravanzola C; Mareschi K; Rustichell D; Novo E; Sanavio F; Cannito S; Zamara E; Bertero M; Davit A; Francica S; Novelli F; Colombatto S; Fagioli F; Parola M
    Gut; 2008 Feb; 57(2):223-31. PubMed ID: 17639088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
    Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
    Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P
    Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction.
    Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT
    J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage.
    François S; Bensidhoum M; Mouiseddine M; Mazurier C; Allenet B; Semont A; Frick J; Saché A; Bouchet S; Thierry D; Gourmelon P; Gorin NC; Chapel A
    Stem Cells; 2006 Apr; 24(4):1020-9. PubMed ID: 16339642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
    Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N
    Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-1 sustains stem cell mediated renal repair.
    Imberti B; Morigi M; Tomasoni S; Rota C; Corna D; Longaretti L; Rottoli D; Valsecchi F; Benigni A; Wang J; Abbate M; Zoja C; Remuzzi G
    J Am Soc Nephrol; 2007 Nov; 18(11):2921-8. PubMed ID: 17942965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
    Xia Z; Locklin RM; Triffitt JT
    Eur J Cell Biol; 2008 Jun; 87(6):353-64. PubMed ID: 18417247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice.
    Xia Z; Ye H; Choong C; Ferguson DJ; Platt N; Cui Z; Triffitt JT
    J Biomed Mater Res A; 2004 Dec; 71(3):538-48. PubMed ID: 15481051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
    Qi S; Wu D
    Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.